U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
REOZALIMAB
INN  
Official Name English
LY3434172, A PD-1 AND PD-L1 BISPECIFIC ANTIBODY
Code English
IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE,271-SERINE,189-LYSINE,220-ARGININE,356-VALINE,357-TYROSINE,411-ALANINE,413-VALINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL LY3300054 .GAMMA.1-CHAIN), DISULFIDE WITH (179-GLUTAMIC ACID,181-GLUTA
Common Name English
LY-3434172
Code English
LY3434172
Code English
reozalimab [INN]
Common Name English
Code System Code Type Description
INN
11904
Created by admin on Sat Dec 16 14:25:01 GMT 2023 , Edited by admin on Sat Dec 16 14:25:01 GMT 2023
PRIMARY
FDA UNII
1LO2LQW7QG
Created by admin on Sat Dec 16 14:25:01 GMT 2023 , Edited by admin on Sat Dec 16 14:25:01 GMT 2023
PRIMARY
CAS
2445259-99-2
Created by admin on Sat Dec 16 14:25:01 GMT 2023 , Edited by admin on Sat Dec 16 14:25:01 GMT 2023
PRIMARY
NCI_THESAURUS
C160605
Created by admin on Sat Dec 16 14:25:01 GMT 2023 , Edited by admin on Sat Dec 16 14:25:01 GMT 2023
PRIMARY
ACTIVE MOIETY
REOZALIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966